{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-024741","form_type":"8-K","ticker":"CING","cik":"0001862150","company_name":"Cingulate Inc.","filed_at":"2025-08-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.426291+00:00","generated_at":"2026-05-17T11:33:37.997133+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Cingulate Q2 net loss widens to $4.8M; files NDA for CTx-1301 with FDA","bullets":["Net loss of $4.8M in Q2 2025, up from $3.2M in Q2 2024; R&D spend +43.6% to $2.7M.","Cash and cash equivalents $8.9M as of June 30, 2025; expects cash needs into late 2025; needs ~$1.5M more for commercialization.","Submitted NDA to FDA for lead asset CTx-1301 (dexmethylphenidate) on July 31, 2025; FDA decision on acceptance expected in 60 days.","Executed $25M purchase agreement with Lincoln Park Capital for at-the-market common stock sales over 36 months.","Phase 3 pediatric study showed marked improvement in ADHD symptoms at week five."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-024741","json":"https://secwatch.observer/filing/0001641172-25-024741.json","markdown":"https://secwatch.observer/filing/0001641172-25-024741.md","text":"https://secwatch.observer/filing/0001641172-25-024741.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1862150/000164117225024741/0001641172-25-024741-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1862150/000164117225024741/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T11:33:37.997133+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}